Association study between salivary levels of interferon (IFN)-gamma, interleukin (IL)-17, IL-21, and IL-22 with chronic periodontitis

Archives of Oral Biology

Volumn 60, Issue 1, 2015, Pages 91-99

  Isaza Guzman D M ^a   Cardona Velez N ^a   Gaviria Correa, D E ^a   Martinez Pabon M C ^a   Castano Granada M C ^a   Tobon Arroyave S I ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Chronic periodontitis; IFN ; IL 17; IL 21; IL 22; Saliva

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ADULT; CASE CONTROL STUDY; CHEMISTRY; CHRONIC PERIODONTITIS; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; REPRODUCIBILITY; SALIVA;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHRONIC PERIODONTITIS; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKINS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SALIVA;

EID: 84908439471     PISSN: 00039969     EISSN: 18791506     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2014.09.002     Document Type: Article

References (49)

1. Tietze K, Dalpke A, Morath S, Mutters R, Heeg K, Nonnenmacher C. Differences in innate immune responses upon stimulation with Gram-positive and Gram-negative bacteria. J Periodontal Res 2006;41 (5):447-54.
2. Gemmell E, Yamazaki K, Seymour GJ. Destructive periodontitis lesions are determined by the nature of the lymphocytic response. Crit Rev Oral Biol Med 2002;13(1):17-34.
3. Sallusto F, Lanzavecchia A. Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity. Eur J Immunol 2009;39(8):2076-82.
4. Garlet GP. Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints. J Dent Res 2010;89(12):1349-63.
5. Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 2004;202:8-32.
6. Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 2007;96:41-101.
7. Preshaw PM, Taylor JJ. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J Clin Periodontol 2011;38(Suppl. 11):60-84.
8. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136(7):2348-57.
9. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005;6 (11):1123-32.
10. Kolls JK, Khader SA. The role of Th17 cytokines in primary mucosal immunity. Cytokine Growth Factor Rev 2010;21 (6):443-8.
11. Yu JJ, Ruddy MJ, Wong GC, Sfintescu C, Baker PJ, Smith JB, et al. An essential role for IL-17 in preventing pathogeninitiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 2007;109(9):3794-802.
12. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008;14(3):275-81.
13. Gaffen SL, Hajishengallis G. A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res 2008;87 (9):817-28.
14. Bickel M, Axtelius B, Solioz C, Attström R. Cytokine gene expression in chronic periodontitis. J Clin Periodontol 2001;28 (9):840-7.
15. Cardoso CR, Garlet GP, Crippa GE, Rosa AL, Júnior WM, Rossi MA, et al. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol Immunol 2009;24(1):1-6.
16. Dutzan N, Rivas C, García-Sesnich J, Henríquez L, Rivera O, Dezerega A, et al. Levels of interleukin-21 in patients with untreated chronic periodontitis. J Periodontol 2011;82 (10):1483-9.
17. Adibrad M, Deyhimi P, Ganjalikhani Hakemi M, Behfarnia P, Shahabuei M, Rafiee L. Signs of the presence of Th17 cells in chronic periodontal disease. J Periodontal Res 2012;47(4):525-31.
18. Dutzan N, Vernal R, Vaque JP, García-Sesnich J, Hernandez M, Abusleme L, et al. Interleukin-21 expression and its association with proinflammatory cytokines in untreated chronic periodontitis patients. J Periodontol 2012;83(7):948-54.
19. Kato-Kogoe N, Nishioka T, Kawabe M, Kataoka F, Yamanegi K, Yamada N, et al. The promotional effect of IL-22 on mineralization activity of periodontal ligament cells. Cytokine 2012;59(1):41-8.
20. Navarrete M, García J, Dutzan N, Henríquez L, Puente J, Carvajal P, Hernandez M, et al. Interferon-g, interleukins-6 and -4, and factor XIII-A as indirect markers of the classical and alternative macrophage activation pathways in chronic periodontitis. J Periodontol 2014;85(5):751-60.
21. Papathanasiou E, Teles F, Griffin T, Arguello E, Finkelman M, Hanley J, et al. Gingival crevicular fluid levels of interferon-γ, but not interleukin-4 or -33 or thymic stromal lymphopoietin, are increased in inflamed sites in patients with periodontal disease. J Periodontal Res 2014;49(1):55-61.
22. Napimoga MH, Nunes LH, Maciel AA, Demasi AP, Benatti BB, Santos VR, et al. Possible involvement of IL-21 and IL-10 on salivary IgA levels in chronic periodontitis subjects. Scand J Immunol 2011;74(6):596-602.
23. Ozc¸aka O, Nalbantsoy A, Buduneli N. Interleukin-17 and interleukin-18 levels in saliva and plasma of patients with chronic periodontitis. J Periodontal Res 2011;46(5):592-8.
24. Prakasam S, Srinivasan M. Evaluation of salivary biomarker profiles following non-surgical management of chronic periodontitis. Oral Dis 2014;20(2):171-7.
25. Ng PY, Donley M, Hausmann E, Hutson AD, Rossomando EF, Scannapiecco FA. Candidate salivary biomarkers associated with alveolar bone loss: cross-sectional and in vitro studies. FEMS Immunol Med Microbiol 2007;49(2):252-60.
26. Frodge BD, Ebersole JL, Kryscio RJ, Thomas MV, Miller CS. Bone remodeling biomarkers of periodontal disease in saliva. J Periodontol 2008;79(10):1913-9.
27. Miller CS, Foley JD, Bailey AL, Campell CL, Humphries RL, Christodoulides N, et al. Current developments in salivary diagnostics. Biomark Med 2010;4(1):171-89.
28. Gursoy UK, Könönen E, Pussinen PJ, Tervahartiala T, Hyvärinen K, Suominen AL, et al. Use of host- and bacteria-derived salivary markers in detection of periodontitis: a cumulative approach. Dis Markers 2011;30(6):299-305.
29. Teles RP, Likhari V, Socransky SS, Haffajee AD. Salivary cytokine levels in subjects with chronic periodontitis and in periodontally healthy individuals: a cross-sectional study. J Periodontal Res 2009;44(3):411-7.
30. Engebretson SP, Vossughi F, Hey-Hadavi J, Emingil G, Grbic JT. The influence of diabetes on gingival crevicular fluid betaglucuronidase and interleukin-8. J Clin Periodontol 2006;33 (11):784-90.
31. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4(1):1-6.
32. Lindhe J, Ranney R, Lamster I, Charles A, Chung C-P, Fleming T, et al. Consensus report: chronic periodontitis. Ann Periodontol 1999;4(1):38.
33. Wang H, Luo Z, Lei L, Sun Z, Zhou M, Dan H, et al. Interaction between oral lichen planus and chronic periodontitis with Th17-associated cytokines in serum. Inflammation 2013;36(3):696-704.
34. Cheng WC, Hughes FJ, Taams LS. The presence, function and regulation of IL-17 and Th17 cells in periodontitis. J Clin Periodontol 2014; 41(6):541-9.
35. Gomes MA, Rodrigues FH, Afonso-Cardoso SR, Buso AM, Silva AG, Favoreto Jr S et al. Levels of immunoglobulin A1 and messenger RNA for interferon gamma and tumor necrosis factor alpha in total saliva from patients with diabetes mellitus type 2 with chronic periodontal disease. JPeriodontal Res 2006;41(3):177-83.
36. Isaza-Guzmán DM, Aristizábal-Cardona D, Martínez-Pabón MC, Velásquez-Echeverri H, Tobón-Arroyave SI. Estimation of sCD14 levels in saliva obtained from patients with various periodontal conditions. Oral Dis 2008;14(5):450-6.
37. Tobón-Arroyave SI, Jaramillo-González PE, Isaza-Guzmán DM. Correlation between salivary IL-1beta levels and periodontal clinical status. Arch Oral Biol 2008;53(4):346-52.
38. Tobón-Arroyave SI, Isaza-Guzmán DM, Restrepo-Cadavid EM, Zapata-Molina SM, Martínez-Pabón MC. Association of salivary levels of the bone remodelling regulators sRANKL and OPG with periodontal clinical status. J Clin Periodontol 2012;39(12):1132-40.
39. Boldrick JC, Alizadeh AA, Diehn M, Dudoit S, Liu CL, Belcher CE, et al. Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proc Natl Acad Sci U S A 2002;99(2):972-7.
40. Górska R, Gregorek H, Kowalski J, Laskus-Perendyk A, Syczewska M, Madaliński K. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis. J Clin Periodontol 2003;30(12):1046-52.
41. Dutzan N, Gamonal J, Silva A, Sanz M, Vernal R. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL)-17, IL-10 and transforming growth factorbeta during the progression of chronic periodontitis. J Clin Periodontol 2009; 36(5):396-403.
42. Myer RG, El Mezayen R, High KP. Prostaglandin E2-dependent IL-23 production in aged murine dendritic cells. Exp Gerontol 2010;45(11):834-41.
43. Qiu Y, Huang Y, Chen J, Qiao D, Zeng G, Cai J. Depletion of IL-22 during culture enhanced antigen-driven IFN-γ production by CD4(+)T cells from patients with active TB. Immunol Lett 2013;150 (1-2):48-53.
44. Lin H, Tong ZH, Xu QQ, Wu XZ, Wang XJ, Jin XG, et al. Interplay of Th1 and Th17 cells in murine models of malignant pleural effusion. Am J Respir Crit Care Med 2014;189(6):697-706.
45. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005;6(11):1133-41.
46. Ouyang W, Valdez P. IL-22 in mucosal immunity. Mucosal Immunol 2008;1(5):335-8.
47. Sonnenberg GF, Fouser LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 2011;12 (5):383-90.
48. Yen CJ, Lin SL, Huang KT, Lin RH. Age-associated changes in interferon-gamma and interleukin-4 secretion by purified human CD4+ and CD8+ T cells. J Biomed Sci 2000;7(4):317-21.
49. Vasto S, Candore G, Balistreri CR, Caruso M, Colonna-Romano G, Grimaldi MP, et al. Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev 2007;128(1):83-91.